Raj D. Pai advises clients in the biotechnology, pharmaceuticals and medical devices fields through the patent preparation and prosecution process in addition to assisting with portfolio development, including opinions and performing third-party patent landscape analyses.

    Prior to his law practice, Raj’s postdoctoral work focused on analyzing signaling pathways in leukemic cells, parasitology studies, and biofuel production. He holds a Ph.D. from the University of California Berkeley, where he carried out biochemical and structural studies on the bacterial ribosome.

    While in law school, he served as president of the King Hall Intellectual Property Law Association and articles selection editor for the University of California Davis School of Law Business Law Journal.

    Award Mouse thought multimedia interface book medal screen monitor
    • Representing various biotechnology companies in the development and management of patent portfolios related to antibodies and antibody drug candidates.
    • Assisting chemical companies in the development and management of patent portfolios related to small molecule production and sustainable products.
    • Representing medical device companies in the development and management of patent portfolios related medical devices.

    Education

    • University of California Davis School of Law, J.D., 2017
    • University of California, Berkeley, Ph.D., 2008
    • University of Minnesota, Twin Cities, B.S., summa cum laude

    Admissions

    • California, 2017
    • U.S. Patent and Trademark Office

    Languages

    • English
    • Spanish
    {{blog.displayDate}}
    {{blog.title}} {{blog.source}}
    Award Mouse thought multimedia interface book medal screen monitor